News for AdaptHealth Corp. (AHCO)

AdaptHealth (AHCO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

On June 30, 2025, BlackRock, Inc. (Trades, Portfolio) executed a significant transaction involving AdaptHealth Corp (AHCO), reducing its holdings by 1,252,869 s

Market Analysis by covering: Aspen Aerogels Inc, Adapthealth Corp, Yalla Group Ltd, Integral Ad Science Holding LLC. Read 's Market Analysis on Investing.com

AdaptHealth Corp. (NASDAQ:AHCO) is one of the best undervalued medical device stocks to buy now. In a report released on July 1, David S Macdonald from Truist Financial maintained a Buy rating on AdaptHealth Corp. (NASDAQ:AHCO) without a price target. AdaptHealth Corp. (NASDAQ:AHCO) reported $95.5 million in cash flow from operations in fiscal Q1 2025, an […]

AdaptHealth Corp. (NASDAQ: AHCO) (”œAdaptHealth” or the ”œCompany”), a national leader in providing patient-centered, healthcare-at-home solutions includ

U.S. stock futures were higher this morning, with the Dow futures gaining over 100 points on Friday. Shares of Concentrix Corporation CNXC fell sharply in toda...

STERIS has outpaced the broader healthcare sector over the past year and analysts are reasonably bullish on its future prospects.

AdaptHealth Corp. (NASDAQ: AHCO) (”œAdaptHealth” or the ”œCompany”), a national leader in providing patient-centered, healthcare-at-home solutions includ

Truist Securities analyst David Macdonald has maintained a "Buy" rating on AdaptHealth (AHCO), while adjusting the 12-month price target. The revised target is

Truist has adjusted its price target for AdaptHealth (AHCO), lowering it to $13 from a previous $14. Despite the reduction, the firm maintains a Buy rating on t

On December 31, 2024, Pacer Advisors, Inc. (Trades, Portfolio) executed a noteworthy transaction by acquiring 8,011,702 shares of AdaptHealth Corp (AHCO) at a p

In a recent analyst update, RBC Capital's Ben Hendrix has maintained an

Key Takeaways: AdaptHealth (AHCO) exceeded Q1 2025 revenue expectations with $777.9 million. The company's debt reduction initiatives have successfully c

Discover insights from AdaptHealth’s Q1 2025 earnings call, featuring revenue growth in Respiratory Health, operational improvements, and debt reduction...

AdaptHealth Corp. (NASDAQ:AHCO) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ETCompany ParticipantsSuzanne Foster - CEOJason Clemens - CFOConference...

California-based Marin Software Incorporated (MRIN) is up over 141 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

AdaptHealth Corp's Q4 2024 results exceeded expectations with a 12.3% margin. See why trends in sleep apnea treatment make AHCO stock a strong Buy.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

AdaptHealth Corp showcases resilience with a diverse product portfolio and robust technology integration.Operational efficiency and strategic acquisitions fuel